|
Peptilogics, Inc.
Pittsburgh, USA
|
|
Peptilogics is a surgical therapeutics company dedicated to curing and preventing devastating medical device-related infections. The company’s lead candidate, zaloganan (PLG0206), is a first-in-class, broad-spectrum anti-biofilm drug candidate currently being evaluated in the RETAIN Phase 2/3 registration trial for the treatment of prosthetic joint infection.